ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice

[1]  S. Leurgans,et al.  Hippocampal ProNGF Signaling Pathways and &bgr;-Amyloid Levels in Mild Cognitive Impairment and Alzheimer Disease , 2012, Journal of neuropathology and experimental neurology.

[2]  M. Costanzi,et al.  Loss of NGF-TrkA Signaling from the CNS Is Not Sufficient to Induce Cognitive Impairments in Young Adult or Intermediate-Aged Mice , 2012, The Journal of Neuroscience.

[3]  B. Hempstead,et al.  Neurotrophic actions initiated by proNGF in adult sensory neurons may require peri‐somatic glia to drive local cleavage to NGF , 2012, Journal of neurochemistry.

[4]  G. Bernardi,et al.  Hippocampus versus entorhinal cortex decoupling by an NR2 subunit–specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy , 2012, Epilepsia.

[5]  Ashley M. Fortress,et al.  Cholinergic Degeneration and Alterations in the TrkA and p75NTR Balance as a Result of Pro-NGF Injection into Aged Rats , 2011, Journal of aging research.

[6]  I. Arisi,et al.  NGF and proNGF Regulate Functionally Distinct mRNAs in PC12 Cells: An Early Gene Expression Profiling , 2011, PloS one.

[7]  W. Mobley,et al.  Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer’s disease , 2011, Journal of neurochemistry.

[8]  E. Mufson,et al.  Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice , 2011, Neurobiology of Disease.

[9]  Zheng Zachory Wei,et al.  Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. , 2011, Current Alzheimer research.

[10]  Julie A. Harris,et al.  Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network , 2010, Neuron.

[11]  A. Verkhratsky,et al.  Astrocytes in Alzheimer’s disease , 2010, Neurotherapeutics.

[12]  A. Crespel,et al.  Senile myoclonic epilepsy: Delineation of a common condition associated with Alzheimer's disease in Down syndrome , 2010, Seizure.

[13]  A. Cattaneo,et al.  Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration , 2010, Proceedings of the National Academy of Sciences.

[14]  G. Bernardi,et al.  Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease. , 2010, Learning & memory.

[15]  B. Abou-Khalil.  How Important is alzheimer's Disease as a Risk Factor for Unprovoked Seizures and Epilepsy in the Elderly? , 2010, Epilepsy currents.

[16]  E. Cherubini,et al.  In the Adult Hippocampus, Chronic Nerve Growth Factor Deprivation Shifts GABAergic Signaling from the Hyperpolarizing to the Depolarizing Direction , 2010, The Journal of Neuroscience.

[17]  I. Ferrer,et al.  Cell death and learning impairment in mice caused by in vitro modified pro-NGF can be related to its increased oxidative modifications in Alzheimer disease. , 2009, The American journal of pathology.

[18]  D. Walsh,et al.  Alzheimer's disease: synaptic dysfunction and Aβ , 2009, Molecular Neurodegeneration.

[19]  A. Cuello,et al.  Amyloid &bgr;-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.

[20]  D. Svergun,et al.  Intrinsic structural disorder of mouse proNGF , 2009, Proteins.

[21]  K. Neet,et al.  Biological Activity of Nerve Growth Factor Precursor Is Dependent upon Relative Levels of Its Receptors* , 2009, The Journal of Biological Chemistry.

[22]  A. Cattaneo,et al.  Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers. , 2009, Journal of molecular biology.

[23]  L. Mucke,et al.  Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.

[24]  L. Puglielli,et al.  Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit? , 2008, Neurobiology of Aging.

[25]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[26]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[27]  Marco Domeniconi,et al.  Pro-NGF secreted by astrocytes promotes motor neuron cell death , 2007, Molecular and Cellular Neuroscience.

[28]  E. Cherubini,et al.  Nicotine‐induced enhancement of synaptic plasticity at CA3–CA1 synapses requires GABAergic interneurons in adult anti‐NGF mice , 2006, The Journal of physiology.

[29]  A. Cattaneo,et al.  On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease , 2006, Cellular and Molecular Neurobiology.

[30]  Ramiro D. Almeida,et al.  Interaction of Survival and Death Signaling in Basal Forebrain Neurons: Roles of Neurotrophins and Proneurotrophins , 2006, The Journal of Neuroscience.

[31]  A. Cuello,et al.  Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Wuu,et al.  Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease , 2006, Journal of neurochemistry.

[33]  M. Menéndez.  Down syndrome, Alzheimer's disease and seizures , 2005, Brain and Development.

[34]  William J Tyler,et al.  Synaptic vesicle recycling studied in transgenic mice expressing synaptopHluorin , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Mufson,et al.  The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. , 2005, Journal of neuropathology and experimental neurology.

[36]  Z. Salehi,et al.  Nerve growth factor level in the cerebrospinal fluid in hydrocephalus , 2004, Cerebrospinal Fluid Research.

[37]  J. Wuu,et al.  Increased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease , 2004, Journal of neuropathology and experimental neurology.

[38]  M. Meyer,et al.  Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Barbara L. Hempstead,et al.  Sortilin is essential for proNGF-induced neuronal cell death , 2004, Nature.

[40]  J. Kim,et al.  ProNGF Induces p75-Mediated Death of Oligodendrocytes following Spinal Cord Injury , 2002, Neuron.

[41]  M. Avoli,et al.  Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro , 2002, Progress in Neurobiology.

[42]  Barbara L. Hempstead,et al.  Regulation of Cell Survival by Secreted Proneurotrophins , 2001, Science.

[43]  B. Michalski,et al.  The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease , 2001, Molecular and Cellular Neuroscience.

[44]  E Schwarz,et al.  The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. , 2001, European journal of biochemistry.

[45]  G. Feng,et al.  Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP , 2000, Neuron.

[46]  N. Berardi,et al.  Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice , 2000 .

[47]  G. Adler,et al.  Commercial Recombinant Human β‐Nerve Growth Factor and Adult Rat Dorsal Root Ganglia Contain an Identical Molecular Species of Nerve Growth Factor Prohormone , 2000, Journal of neurochemistry.

[48]  H. Stunnenberg,et al.  Leukemic transformation by the v‐ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo , 1998, The EMBO journal.

[49]  F. Pavone,et al.  Prevention of amitriptyline-induced avoidance impairment by tacrine in mice , 1997, Behavioural Brain Research.

[50]  Pico Caroni,et al.  Overexpression of growth-associated proteins in the neurons of adult transgenic mice , 1997, Journal of Neuroscience Methods.

[51]  M Chrétien,et al.  Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. , 1996, The Biochemical journal.

[52]  M. Barbacid,et al.  The trk proto-oncogene encodes a receptor for nerve growth factor , 1991, Cell.

[53]  D. Kaplan,et al.  Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF , 1991, Nature.

[54]  M. Vidal,et al.  Tissue‐specific control elements of the Thy‐1 gene. , 1990, The EMBO journal.

[55]  A. Cattaneo,et al.  Three Distinct Types of Monoclonal Antibodies After Long‐Term Immunization of Rats with Mouse Nerve Growth Factor , 1988, Journal of neurochemistry.

[56]  U. Francke,et al.  The human gene for the beta subunit of nerve growth factor is located on the proximal short arm of chromosome 1. , 1983, Science.

[57]  W. Rutter,et al.  Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor , 1983, Nature.

[58]  U. Armato,et al.  Hippocampal membrane-associated p75NTR levels are increased in Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[59]  A. Cattaneo,et al.  Towards non invasive nerve growth factor therapies for Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[60]  J. Hardy,et al.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes , 1998, Nature Medicine.